++
Section 9: Gynecologic and Obstetric Disorders
++
++
++
Which of the following drug properties limits the ability of a drug to readily transfer across the placenta:
++
++
++
++
++
B. Molecular weight below 500 daltons
++
++
++
++
+
+
++
++
++
Which of the following types of data to evaluate drug safety during pregnancy is least likely to be available?
++
++
++
A. Case study or case series
++
++
++
++
C. Retrospective cohort study
++
++
D. Randomized, controlled trial
+
+
++
++
++
A 36-year-old woman with an active seizure disorder is contemplating pregnancy. Your recommendation to her is:
++
++
++
A. Switch antiepileptic treatment to a medication not known to cause neural tube defects
++
++
B. Take folic acid 4 mg daily during the first trimester
++
++
C. Take folic acid 4 mg daily before conception followed by 4 mg daily during at least the first trimester
++
++
D. Increase dietary intake of folic acid
+
+
++
++
++
A 29-year-old woman who is at week 37 is complaining of constipation for the past 3 days despite increasing her dietary fiber and water intake. Which of the following recommendations is not appropriate?
++
++
++
++
++
++
++
++
++
++
++
E. None of the above is appropriate
+
+
++
++
++
Which of the following interventions decreases the risk of developing preeclampsia during pregnancy in women at risk for preeclampsia?
++
++
++
++
++
++
++
C. Oral calcium supplementation
++
++
++
++
E. Intravenous magnesium sulfate infusion
+
+
++
++
++
For a woman at 34 weeks of gestation with an acute deep vein thrombosis, the treatment of choice is:
++...